Press Releases

Inizio Evoke Supercharges Creative Leadership with Dual ECD Appointments

ELRIG Announces Keynote Speakers for Drug Discovery 2025

• Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science” • Event supported by VisitBritain showcases UK life science sector and extends international reach

Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer  

GeneFab and RegCell Announce Strategic Partnership to Advance Autoimmune Cell Therapy into U.S. Clinical Trials

GenNext Technologies and Thermo Fisher Scientific Collaborate to Simplify Structural Biology for Faster Biotherapeutic Development

GenNext® Technologies, Inc. is collaborating with Thermo Fisher Scientific to provide a simplified structural biology workflow designed to improve biotherapeutic development

Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development

Elegen expanded it's ENFINIA cell-free gene synthesis platform with the launch of an early access program for IVT Ready DNA targeted toward RNA therapeutics, cell and gene therapies, and personalized cancer vaccines. ENFINIA IVT Ready DNA offers full-length, high-complexity, high-accuracy linear DNA with a long poly(A) tail, manufactured cell-free and delivered in as few as 10 days, ready for immediate use to speed genetic medicine development.

Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development

Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies, supporting the development of more targeted treatment decisions and advancing pharmaceutical R&D.

Gifthealth Appoints Chip Parkinson as Chief Executive Officer to Accelerate Growth and Innovation in Pharmacy Services

Gifthealth, a technology-driven pharmacy care company dedicated to making prescription access easier and more affordable, is pleased to announce the appointment of Chip Parkinson as its new Chief Executive Officer.

Emmes Groups' OptymEdge to launch the first dedicated ophthalmology clinical trial platform at ARVO 2025

Symbiosis Honoured with Prestigious King’s Award for Enterprise for International Trade

Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing Capacity

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

Viz.ai Launches Viz 3D CTA™ to Deliver Enhanced Imaging and Accelerate Clinical Decision-Making

New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows.

Aplos Analytics Expands Cloud-Based Platform to Include Custom Outputs

Aplos NCA includes new features to support custom data processing, flexible table and figure creation, and the ability to create custom reports using user-defined templates.

EpiCypher Launches Novel, Affordable DNA Methylation Sequencing Assays to Accelerate Drug Discovery

EpiCypher® has announced the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery.

Mundipharma announces availability of REZZAYO® (rezafungin) for adult patients with invasive candidiasis following Health Service Executive reimbursement agreement1

Two New Clinical Studies Demonstrate Accuracy of Viz.ai Algorithm for Intracranial Hemorrhage Volume Measurements to Advance Timely, Critical Treatment Decisions

Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation

Phenomix Sciences and Mayo Clinic to Present Landmark Research at DDW 2025, Advancing Precision Obesity Medicine

The extensive body of research from Mayo Clinic emphasizes major advancements in obesity, including prediction of GLP-1 side effects, a new obesity sub-phenotype, and insights into personalized bariatric and endoscopic procedures.

Symbiosis Earns Recognition from EcoVadis for Commitment to Sustainability

Symbiosis Pharmaceutical Services, a specialist sterile manufacturing CMO, who has been formally recognised by EcoVadis for its continued commitment to sustainability.

VieCure Integrates NCCN Content into Leading Technology Platform for Community Oncology Care

VieCure is making thousands of the most commonly used NCCN Chemotherapy Order Templates available on its Halo Intelligence Platform